IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 1.432
-0.040 (-2.72%)
Apr 24, 2026, 3:04 PM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 122.99 million as of April 24, 2026. Its market cap has decreased by -69.44% in one year.
Market Cap
122.99M
Enterprise Value
71.08M
Revenue
57.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.43
Market Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 122.99M, a decrease of -70.22%. That is a compound annual growth rate of -12.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 125.03M | -25.28% |
| Dec 30, 2025 | 167.33M | -69.99% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 174.24M |
| Diamyd Medical AB | 170.48M |
| Elicera Therapeutics AB | 157.50M |
| AlzeCure Pharma AB | 156.28M |
| Alligator Bioscience AB | 138.50M |
| NextCell Pharma AB | 131.44M |
| Simris Group AB (PUBL) | 120.40M |
| Annexin Pharmaceuticals AB | 102.36M |